News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
392,851 Results
Type
Article (18739)
Company Profile (113)
Press Release (373999)
Section
Business (120942)
Career Advice (709)
Deals (23582)
Drug Delivery (75)
Drug Development (56232)
Employer Resources (67)
FDA (9780)
Job Trends (8554)
News (214160)
Policy (19854)
Tag
Academia (896)
Alliances (30088)
Alzheimer's disease (769)
Approvals (9786)
Artificial intelligence (119)
Bankruptcy (220)
Best Places to Work (6597)
Breast cancer (122)
Cancer (1042)
Cardiovascular disease (81)
Career advice (620)
CAR-T (74)
Cell therapy (202)
Clinical research (46530)
Collaboration (381)
Compensation (138)
COVID-19 (1197)
C-suite (99)
Data (1093)
Diabetes (123)
Diagnostics (3053)
Drug pricing (75)
Earnings (50470)
Events (56463)
Executive appointments (343)
FDA (10333)
Funding (287)
Gene therapy (151)
GLP-1 (391)
Government (2102)
Healthcare (8274)
Infectious disease (1246)
Inflammatory bowel disease (79)
Interviews (97)
IPO (10826)
Job creations (2315)
Job search strategy (552)
Layoffs (197)
Legal (4387)
Lung cancer (154)
Lymphoma (77)
Manufacturing (158)
Medical device (5392)
Medtech (5395)
Mergers & acquisitions (13019)
Metabolic disorders (328)
Neuroscience (1010)
NextGen: Class of 2025 (2675)
Non-profit (1203)
Northern California (1194)
Obesity (184)
Opinion (147)
Parkinson's disease (71)
Patents (109)
People (34852)
Phase I (14029)
Phase II (20416)
Phase III (15886)
Pipeline (489)
Postmarket research (1642)
Preclinical (5455)
Radiopharmaceuticals (165)
Rare diseases (199)
Real estate (3175)
Regulatory (14379)
Research institute (943)
Resumes & cover letters (89)
Southern California (1082)
Startups (1986)
United States (10800)
Vaccines (218)
Weight loss (127)
Date
Last 7 days (432)
Last 30 days (1707)
Last 365 days (22846)
2025 (1750)
2024 (23160)
2023 (26081)
2022 (33044)
2021 (34275)
2020 (32189)
2019 (23604)
2018 (17974)
2017 (20130)
2016 (18370)
2015 (22006)
2014 (16825)
2013 (13797)
2012 (14600)
2011 (15378)
2010 (14158)
Location
Africa (418)
Arizona (76)
Asia (28117)
Australia (5679)
California (2725)
Canada (1151)
China (275)
Colorado (130)
Connecticut (145)
Europe (53914)
Florida (416)
Illinois (237)
Indiana (154)
Japan (90)
Maryland (388)
Massachusetts (2187)
Minnesota (136)
New Jersey (941)
New York (839)
North Carolina (512)
Northern California (1194)
Ohio (70)
Pennsylvania (688)
South America (664)
Southern California (1082)
Texas (394)
Virginia (70)
Washington State (325)
392,851 Results for "alembic pharmaceuticals limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Telix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.
ARTMS Inc. (ARTMS) is pleased to announce that the acquisition by Telix Pharmaceuticals Limited (Telix) has been completed.
April 11, 2024
·
3 min read
Business
Cosette Pharmaceuticals and Alembic Pharmaceuticals Limited Announce the Approval and Launch of a National Brand Equivalent (NBE) of Abreva® (Docosanol Cream 10%) Including the First Approval in the Pump Format
Cosette Pharmaceuticals, Inc (“Cosette”), in collaboration with Aleor Dermaceuticals, a wholly owned subsidiary of Alembic Pharmaceuticals (“Alembic”; BSE: 533573), announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Application (ANDA) for an NBE version of Abreva® (Docosanol cream 10%) in a 2 gm tube and pump formats.
May 24, 2022
·
2 min read
BioCapital
Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan
Vanda Pharmaceuticals Inc. announced that its Board of Directors has adopted a limited duration stockholder rights plan to protect stockholder interests and maximize value for all stockholders.
April 17, 2024
·
5 min read
Aurigene Pharmaceutical Services Limited, a global CRDMO, announces the opening of its biologics facility offering process development and clinical scale manufacturing capabilities
Aurigene Pharmaceutical Services Limited (“Aurigene”), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft. in Genome Valley
June 3, 2024
·
4 min read
Press Releases
Dynavax Adopts Limited-Duration Stockholder Rights Plan
October 30, 2024
·
5 min read
Press Releases
IMFINZI® (durvalumab) approved in the US as first and only immunotherapy regimen for patients with limited-stage small cell lung cancer
December 5, 2024
·
19 min read
Press Releases
Piramal Pharma Limited Announces Results for Q3 and 9M FY25
January 29, 2025
·
6 min read
Press Releases
Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering
January 16, 2025
·
5 min read
Piramal Pharma Limited Announces Results for Q4 and FY2024
Piramal Pharma Limited, a leading global pharmaceuticals company, announced its standalone and consolidated results for the Fourth Quarter and Full Year ended 31st March 2024.
May 10, 2024
·
8 min read
Press Releases
Hong Kong Pharma Digital Technology Holdings Limited Announces Pricing of Initial Public Offering
January 14, 2025
·
5 min read
1 of 39,286
Next
